Patent directory · USPTO A61K / A61P
Patents matching “administration”
271 pharma patents match "administration" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 271 pharmaceutical patents matching "administration" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
CA 1341505
PREPARATION D'IMMUNOGLOBULINE POLYCLONALE CONTENANT DE L'IGM, AUX FINS D'ADMINISTRATION INTRAVEINEUSE, AINSI QUE SA METHODE DE FABRICATION
expired -
US 7022315
Administration of a thiol-based chemoprotectant compound
expired -
US 6984379
Gene therapy by administration of genetically engineered CD34+ cells obtained from cord blood
expired -
US 2005215524
Methods and compositions for improving photodynamic therapy through administration of lipids
expired -
US 6946246
Production of functional proteins: balance of shear stress and gravity
expired -
US 6921527
Composition for pulmonary administration comprising a drug and a hydrophobic amino acid
expired -
US 6863901
Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
expired -
US 6846799
Preventing airway mucus production by administration of EGF-R antagonists
expired -
US 6838076
Pulmonary administration of chemically modified insulin
expired -
US 6805858
Methods for the administration of adenovirus p53
expired -
US 6790839
Pharmaceutical administration of adenosine agonists
expired -
US 6730498
Production of functional proteins: balance of shear stress and gravity
expired -
US 6717030
Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse
expired -
US 6638914
Pharmaceutical administration of adenosine agonists
expired -
US 6599449
X-ray crystallography reagent
expired -
US 6569459
Method of administration of paclitaxel-plasma protein formulation
expired -
US 6566324
Preventing airway mucus production by administration of EGF-R antagonists
expired -
US 6558698
Microencapsulated bioactive agents and method of making
expired -
US 6551989
Preventing airway mucus production by administration of EGF-R antagonists
expired -
US 6500455
Tolperison-containing, pharmaceutical preparation for oral administration
expired -
US 6410510
Administration modified ciliary neurotrophic factors
expired -
US 6387399
Microencapsulated bioactive agents and method of making
expired -
US 6368662
Molecular level coating of metal oxide particles
expired -
US 6329349
Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents
expired